Targeted drug tagrisso could be advance against lung cancer
The best treatment for a genetically driven form of lung cancer continues to show lasting benefits, a new clinical trial update shows.
Feb 6, 2023
0
2
The best treatment for a genetically driven form of lung cancer continues to show lasting benefits, a new clinical trial update shows.
Feb 6, 2023
0
2
Heart failure patients who are unvaccinated against SARS-CoV-2, the virus that causes COVID-19, are three times more likely to die if infected with the virus compared to fully boosted heart failure patients, according to ...
Jun 9, 2022
0
13
Scientists have developed a new "precision medicine" approach to treating the damaged DNA in the cancer cells of Pancreatic Cancer patients.
Oct 12, 2020
0
195
Transplanted pancreatic islets in diabetic animals can survive for a long period of time if the animals are treated with short anti-rejection therapy around the time of the transplant. This has been shown by researchers at ...
Feb 1, 2019
0
13
The notorious spike protein of SARS-CoV-2, the virus that causes COVID-19, caused lung cancer cells to die in laboratory studies conducted by researchers at RUSH University Medical Center, who recently published their findings ...
Dec 6, 2022
0
154
An international team of scientists from Gero Discovery LLC, the Institute of Biomedical Research of Salamanca, and Nanosyn, Inc. has found a potential drug that may prevent neuronal death through glucose metabolism modification ...
Aug 29, 2019
0
61
A new study gives insight into how immunotherapies, treatments that help the body's immune system fight cancer, might one day be delivered directly to the brain in order to treat brain tumors.
Aug 29, 2019
0
99
Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system ...
Nov 23, 2022
0
64
A four-drug chemotherapy regimen provided longer overall survival than a two-drug combination in a Phase 3 clinical trial for metastatic pancreatic ductal adenocarcinoma. The study is believed to be the first metastatic pancreatic ...
Jan 20, 2023
0
5
Cancer cells have an uncanny ability to evolve and adapt to overcome the treatments used against them.
Jun 18, 2021
0
16